GlassScriptPhysician profile
Shelley D Shoun
NPI 1467671578
$3,613.91
in general payments reported to CMS, 2019-2025
34 companies · $465 in 2025
The $465 reported for 2025 was more than what 83% of Hospice and Palliative Medicine (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $238).
See the full distribution for Hospice and Palliative Medicine (Obstetrics & Gynecology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $127 · 2021: $594 · 2022: $812 · 2023: $757 · 2024: $505 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,725.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $836.77 | 2019-2024 | Lo Loestrin Fe, Orilissa, Ubrelvy |
| Astellas Pharma US INC | $318.46 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $281.29 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $248.15 | 2021-2025 | Nexplanon |
| Therapeuticsmd, INC. | $206.68 | 2019-2022 | |
| Pfizer INC. | $194.49 | 2019-2025 | |
| Millicent US INC | $172.82 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Myovant Sciences INC. | $136.33 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $128.54 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $114.32 | 2021-2023 | |
| Exeltis, USA INC. | $113.16 | 2020-2025 | Slynd, Tyblume |
| Gynesonics, INC. | $88.60 | 2022 | |
| Hologic Sales and Service, LLC | $84.94 | 2020-2024 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Minerva Surgical, INC | $73.09 | 2023 | |
| Daiichi Sankyo INC. | $57.56 | 2020-2023 | Injectafer |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $55.07 | 2024-2025 | |
| Evofem Biosciences, INC. | $48.38 | 2021-2022 | |
| Scynexis, INC. | $46.78 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.82 | 2019-2021 | |
| Roche Diagnostics Corporation | $44.35 | 2019-2021 | |
| Sage Therapeutics, LLC | $38.06 | 2024-2025 | Zurzuvae |
| Biohaven Pharmaceutical Holding Company LTD. | $37.73 | 2022 | |
| Lupin INC. | $37.44 | 2019 | |
| Avion Pharmaceuticals | $34.62 | 2019-2023 | Balcoltra |
| Coopersurgical, INC. | $24.96 | 2025 | Paragard T 380a |
| Becton, Dickinson and Company | $21.82 | 2022 | |
| Innovation Technologies INC | $19.87 | 2021 | |
| Boston Scientific Corporation | $19.05 | 2025 | Watchman Flx |
| Mylan Pharmaceuticals INC. | $17.93 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.91 | 2023 | Exparel |
| Lilly USA, LLC | $15.12 | 2021 | |
| Duchesnay USA Incorporated | $13.89 | 2019 | |
| Medtronic, INC. | $13.25 | 2022 | |
| Meditrina | $7.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelley Shoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.